Amanda Houlihan

Amanda Houlihan serves as an Acquisition Specialist responsible for managing the full lifecycle of procurement actions, from market research and solicitation development to contract award and administration. She plays a critical role in ensuring the agency’s acquisition activities align with federal regulations, particularly FAR Part 19 and Part 15, while supporting mission-critical supply chain needs. Her portfolio primarily encompasses high-compliance, technical procurements involving pharmaceutical manufacturing, sealing systems, and precision hardware components, requiring deep subject matter expertise in regulatory compliance, technical specifications, and quality assurance protocols. While no specific contractor relationships are currently identifiable due to data limitations, Amanda’s procurement patterns suggest a preference for established manufacturers with proven track records in GMP-compliant production and industrial engineering standards. She engages with a mix of large-capacity producers and qualified small businesses, prioritizing vendors capable of meeting stringent quality control and documentation requirements under FDA and ISO frameworks. Her working relationships reflect a focus on reliability, technical capability, and regulatory adherence over volume-based sourcing. Amanda’s set-aside preferences reveal a strong orientation toward open competition, with 95.2% of acquisitions conducted as non-set-aside procurements. However, she consistently reserves 4.8% of opportunities for Total Small Business Set-Asides under FAR 19.5, demonstrating a measured but intentional commitment to small business participation without compromising mission readiness or supply chain resilience. Her approach reflects a balanced adherence to socioeconomic goals while maintaining procurement efficiency and risk mitigation. Her primary industry focus lies in NAICS 325412 (Pharmaceutical Preparation Manufacturing), where she procures sterile injectables, oral solid dosage forms, and related packaging systems. She also frequently acquires gaskets, seals, and precision hardware components under NAICS 339991 and 332510, indicating expertise in medical device supply chains and industrial instrumentation. Amanda’s technical domain expertise spans pharmaceutical cGMP environments, materials science, and mechanical component specifications, making her a key liaison between technical stakeholders and contracting operations.